Jiangsu Hengrui Medicine announces first extraordinary shareholders meeting

• Jiangsu Hengrui Medicine will hold its first extraordinary shareholders’ meeting in Shanghai on Sept. 24, 2026.
• Shareholders will vote on the proposed adoption of the 2026 H Share Scheme.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Hengrui Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260907-12323585), on September 07, 2026, and is solely responsible for the information contained therein.